W-L Allergy/Cold Brands Help Offset Struggling Zantac 75 Sales In 1Q
This article was originally published in The Tan Sheet
Executive Summary
The recently extended Benadryl franchise led the way in a strong first quarter for Warner-Lambert's stable of allergy/cold products.
You may also be interested in...
Generic Famotidine Launch Delayed By Pepcid AC Pediatric Exclusivity
Private label famotidine 10 mg products will not launch until after April 15 due to FDA's Nov. 21 decision to grant J&J/Merck an additional six months of marketing exclusivity for Pepcid AC after reviewing pediatric data submitted by the firm.
Generic Famotidine Launch Delayed By Pepcid AC Pediatric Exclusivity
Private label famotidine 10 mg products will not launch until after April 15 due to FDA's Nov. 21 decision to grant J&J/Merck an additional six months of marketing exclusivity for Pepcid AC after reviewing pediatric data submitted by the firm.
Generic Famotidine Launch Delayed By Pepcid AC Pediatric Exclusivity
Private label famotidine 10 mg products will not launch until after April 15 due to FDA's Nov. 21 decision to grant J&J/Merck an additional six months of marketing exclusivity for Pepcid AC after reviewing pediatric data submitted by the firm.